Editorial Board
Ichiro Kawahata Ph.D
Laboratory of Pharmacology, Department of Molecular Pharmaceutics, Graduate School of Pharmaceutical Sciences, Tohoku University · Japan
Editorial leadership for Journal of Experimental and Clinical Toxicology ISSN 2641-7669
Research interests
- Neuroscience
- Neuropharmacology
- Pharmacotherapy
Biography
Academic Society Membership:
- Japanese Biochemical Society
- Japanese Pharmacological Society
- Japan Neuroscience Society
- Society for Neuroscience
- Japan Pharmaceutical Society
- The Japan Pharmaceutical Society
Honours, Awards and Prizes:
- Japan Pharmaceutical Society Annual Meeting Excellence Presentation Award (2014)
- INPD The Best Poster Award(2007)
Selected publications
- Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies 2022 cited 98×
- Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia 2020 cited 67×
- Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP+-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons 2019 cited 52×
- Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain 2020 cited 44×
- Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease 2024 cited 43×
- The Role of CaMKII and ERK Signaling in Addiction 2021 cited 37×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JECT for your work?
This journal is guided by Ichiro Kawahata (Laboratory of Pharmacology, Department of Molecular Pharmaceutics, Graduate School of Pharmaceutical Sciences, Tohoku University) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.